| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_981a50a0cf7bf2fadf3501c977fca016 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56 |
| filingDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fae8e80578a21ffcb3397eeafb89db9f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dda89cb9a6f9964657e3ccaa5a96fae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b83454e695b166e04e5309272a05e50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_291b03a9c31063623f9decb9ecd38814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb3481d1558cf5cacf5de0c3d5faa8f1 |
| publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019127473-A |
| titleOfInvention |
Drugs for treatment and / or prevention of multiple sclerosis |
| abstract |
An agent for the treatment and / or prevention of multiple sclerosis is provided. A compound comprising the following chemical formula I or a pharmaceutically acceptable salt thereof: Here R 1 is in particular methoxy. R 2 is in particular methyl. R 3 is in particular trifluoromethyl. This drug shows an accurate effect by oral administration. [Selected figure] Figure 4 |
| priorityDate |
2018-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |